FDA Investigator: Anthony F. Lorenzo

- Anthony F. Lorenzo first started conducting FDA inspections in 2010, with the last inspection in 2023. Over that time, Anthony F. Lorenzo has conducted 13 inspections at 11 companies across 13 sites.

Get Anthony Lorenzo's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Octapharma AB, Stockholm | 2016

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 Seqirus Inc, Holly Springs | 2014

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 Omrix Biopharmacuetical LTD Jerusalem Plant, Jerusalem | 2013

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 Omrix Biopharmacuetical LTD Jerusalem Plant, Jerusalem | 2013

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 Octapharma Pharmazeutika Produktionsges, m.b.h., Vienna | 2012

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 Octapharma AB, Stockholm | 2012

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Elkton | 2012

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 JHP Pharmaceuticals, LLC, Rochester | 2011

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 Cilag AG, Schaffhausen | 2011

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 Baxter Healthcare Corp, Round Lake | 2011

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483

FDA 483 CAF-DAF scrl, Neder-over- Heembeek | 2010

Out-of-stock
Anthony F. Lorenzo
Biologic Form 483